US Stock MarketDetailed Quotes

AZN AstraZeneca

Watchlist
  • 63.770
  • +0.570+0.90%
Trading Nov 21 09:45 ET
197.72BMarket Cap30.73P/E (TTM)

AstraZeneca Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

AstraZeneca Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
13.10B
13.57B
+462.53M
Beat Est.
+14.01%
+18.04%
+3.53%
EPS
0.77
0.46
-0.32
Miss Est.
+73.46%
+3.41%
-41.05%
Analyst Rating
Strong Buy

Nov 21, 2024

AstraZeneca Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.590B--
--2024/Q4-- / 14.135B--
Nov 12, 20242024/Q313.565B / 13.102B--
--2024/Q212.938B / 12.528B--
Apr 25, 20242024/Q112.679B / 11.812B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 13.590B--
--2024/Q4-- / 14.135B--
Nov 12, 20242024/Q313.565B / 13.102B--
--2024/Q212.938B / 12.528B--
Apr 25, 20242024/Q112.679B / 11.812B--

Unlock Free Earnings Estimates

AstraZeneca Earnings Reports

  • 6-K: 9M and Q3 2024 Results

    Nov 13 02:43

  • 6-K: AstraZeneca Invests $3.5 Billion in US

    Nov 12 22:28

  • 6-K: H1 and Q2 2024 Results

    Jul 25 21:09

  • AstraZeneca | 6-K: AstraZeneca to Deliver $80bn Revenue by 2030

    May 21 18:10

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 21, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday-0.06%